Back to Search
Start Over
Rapid Recovery of CD3+CD8+ T Cells on Day 90 Predicts Superior Survival after Unmanipulated Haploidentical Blood and Marrow Transplantation.
- Source :
- PLoS ONE; 6/8/2016, Vol. 11 Issue 6, p1-17, 17p
- Publication Year :
- 2016
-
Abstract
- Background: Rapid immune reconstitution after allogeneic hematopoietic stem cell transplantation (allo-HSCT) is significantly associated with lower infection, relapse and possibly secondary malignancy rates. The aim of this study was to investigate the role of peripheral lymphocyte subsets, especially CD3<superscript>+</superscript>CD8<superscript>+</superscript> cytotoxic T cell recovery, in predicting transplant outcomes, including the overall survival (OS) and non-relapse mortality (NRM) rates after unmanipulated haploidentical blood and marrow transplantation (HBMT). Methods: Peripheral blood samples were obtained from 214 HBMT recipients with hematological malignancies. The peripheral lymphocyte subsets (CD3<superscript>+</superscript> T cells, CD3<superscript>+</superscript>CD4<superscript>+</superscript> helper T cells, CD3<superscript>+</superscript>CD8<superscript>+</superscript> cytotoxic T cells, and CD19<superscript>+</superscript> B cells) were analyzed by flow cytometry at days 30, 60, 90, 180, 270 and 360 after HBMT. Results: The CD3<superscript>+</superscript>CD8<superscript>+</superscript> cytotoxic T cell recovery at day 90 (CD3<superscript>+</superscript>CD8<superscript>+</superscript>-90) was correlated with bacterial infection (P = 0.001), NRM (P = 0.001), leukemia-free survival (LFS, P = 0.005), and OS (P = 0.001) at a cutoff value of 375 cells/μL CD3<superscript>+</superscript>CD8<superscript>+</superscript> T cells. The incidence of bacterial infection in patients with the CD3<superscript>+</superscript>CD8<superscript>+</superscript>-90 at ≥375 cells/μL was significantly lower than that of cases with the CD3<superscript>+</superscript>CD8<superscript>+</superscript>-90 at <375 cells/μL after HBMT (14.6% versus 41.6%, P<0.001). Multivariate analysis showed the rapid recovery of CD3<superscript>+</superscript>CD8<superscript>+</superscript> T cells at day 90 after HBMT was strongly associated with a lower incidence of NRM (HR = 0.30; 95% CI: 0.15–0.60; P = 0.000) and superior LFS (HR = 0.51; 95% CI: 0.32–0.82; P = 0.005) and OS (HR = 0.38; 95% CI: 0.23–0.63; P = 0.000). Conclusion: The results suggest that the rapid recovery of CD3<superscript>+</superscript>CD8<superscript>+</superscript> cytotoxic T cells at day 90 following HBMT could predict superior transplant outcomes. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 19326203
- Volume :
- 11
- Issue :
- 6
- Database :
- Complementary Index
- Journal :
- PLoS ONE
- Publication Type :
- Academic Journal
- Accession number :
- 115985490
- Full Text :
- https://doi.org/10.1371/journal.pone.0156777